GenomeKey has a rapid diagnostic test for sepsis in progress
The UK based company GenomeKey has a rapid diagnostic test for sepsis is in progress. Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is awarding GenomeKey up to $3 million in non-dilutive funding to develop a rapid diagnostic for sepsis. GenomeKey is…